Skip to content

Open Source Vaccine Developer Kits (VDKs)

Alex Hoekstra

Alex Hoekstra introduces Open Source Vaccine Developer Kits (VDKs) to democratize infectious disease research, reduce costs, and accelerate pandemic response.

Summary

The Monopolistic Cost of Proprietary Vaccine Development

Traditional vaccine development is an expensive, proprietary endeavor concentrated within a few multinational pharmaceutical corporations, limiting global equity.

Introducing Open Source Vaccine Developer Kits

Alex Hoekstra presents the concept of Vaccine Developer Kits (VDKs), modular open-source biological tools designed to streamline antigen design, expression, and testing.

Accelerating Rapid Prototyping and Biosecurity Innovation

By lowering the cost barrier and providing standardized testing protocols, VDKs empower researchers worldwide to collaborate on emerging infectious disease countermeasures.

Balancing Open-Science Innovation and Dual-Use Biosecurity

Hoekstra discusses governance models and biosecurity guardrails to ensure distributed vaccine research remains safe, equitable, and transparent.

Related talks